Literature DB >> 23725848

Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance.

Richard C Zink1, Qin Huang, Lu-Yong Zhang, Wen-Jun Bao.   

Abstract

AIM: Combine disproportionality analysis with dynamically interactive graphics to understand spontaneously-reported adverse events in pharmacovigilance.
METHODS: Four statistical methods, including Reporting Odds Ratio, Proportional Reporting Ratio, Multi-Item Gamma Poisson Shrinker and Bayesian Confidence Propagation Neural Network that are used for computing disproportionality are described. Tree maps and other graphical techniques are used to display the disproportionality results.
RESULTS: Spontaneously-reported adverse events in pharmacovigilance are collected from physicians, patients, or the medical literature by regulatory agencies, pharmaceutical companies and device manufacturers to monitor the safety of a product once it reaches the market. In order to identify potential safety-signals, disproportionality analysis methods compare the rate at which a particular event of interest co-occurs with a given drug with the rate this event occurs without the drug in the event database. Tree maps are employed to interactively display the adverse events for particular drugs and compare the adverse events among the drugs.
CONCLUSION: Interactive graphical displays of disproportionality allow the analyst to quickly identify safety signals and perform additional follow-up analyses. Combining statistical methods with dynamically interactive graphics affords insights into the data inaccessible by traditional analysis methods.
Copyright © 2013 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23725848     DOI: 10.1016/S1875-5364(13)60035-7

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  5 in total

1.  Detecting Signals of Disproportionate Reporting from Singapore's Spontaneous Adverse Event Reporting System: An Application of the Sequential Probability Ratio Test.

Authors:  Cheng Leng Chan; Sowmya Rudrappa; Pei San Ang; Shu Chuen Li; Stephen J W Evans
Journal:  Drug Saf       Date:  2017-08       Impact factor: 5.606

2.  New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database.

Authors:  Maurizio Sessa; Morten Andersen
Journal:  BioDrugs       Date:  2021-02-20       Impact factor: 5.807

3.  Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis.

Authors:  Christos Andronis; João Pedro Silva; Eftychia Lekka; Vassilis Virvilis; Helena Carmo; Konstantina Bampali; Margot Ernst; Yang Hu; Irena Loryan; Jacques Richard; Félix Carvalho; Miroslav M Savić
Journal:  Arch Toxicol       Date:  2020-06-05       Impact factor: 5.153

4.  No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database.

Authors:  Andrew A Napoli; Jennifer J Wood; John J Coumbis; Amit M Soitkar; Daniel W Seekins; Hugh H Tilson
Journal:  J Int AIDS Soc       Date:  2014-09-04       Impact factor: 5.396

5.  Ocular adverse events with immune checkpoint inhibitors.

Authors:  Tony Fang; David A Maberley; Mahyar Etminan
Journal:  J Curr Ophthalmol       Date:  2019-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.